You are here

Assessment of SNPs (rs4774, rs6498122) of CIITA Gene in Buccal Swabs and Blood of Oral Lichen Planus Patients in Iraq

Journal Name:

Publication Year:

Abstract (2. Language): 
Background: Oral lichen planus (OLP) is a common autoimmune inflammatory disorder that is difficult to cure, and its pathogenesis is still unknown. The major histocompatibility complex (MHC) class II transactivator (CIITA) gene has been reported to be an important candidate in some classical autoimmune diseases, and certain single nucleotide polymorphisms (SNPs) in CIITA gene have been confirmed to be associated with susceptibility to some autoimmune diseases. This research was conducted to investigate the existence of any correlation between OLP and SNPs (rs4774, rs6498122) in CIITA gene separately and in combination method by using (buccal swabs and blood sample), and to compare their existence with that of apparently healthy group. The validity of DNA extraction method from buccal swabs as convenient, painless, less risk of diseases transition and cost-effective alternatives way to blood sampling for participants and researchers was also assessed in this study. Materials and Methods: A case-control study was performed to genotype detection of 2 SNPs in the CIITA gene from buccal swab and blood sample from OLP patients as patient group, and buccal swab and blood sample from healthy people as control group; this was carried out by qRT-PCR. Results: The SNP rs4774 variant in exon 11 (G/C, Gly500Ala) of CIITA gene is significantly associated with OLP in heterozygous frequency, SNP rs6498122 variant in intron 5 (A/G) of CIITA gene is significantly associated with OLP in mutant frequency, and at allele frequency the two SNPs is significant. When the two SNPs analyzed in genotypes combination method for SNPs (rs4774, rs6498122) between healthy and OLP patient groups, significant result was shown when the rs4774/rs6498122 be wild/mutant and hetero/hetero. Also, the result of DNA extraction for SNPs analyses of buccal swab is the same of blood sample. Conclusion: Data was shown that the two SNPs rs4774 and rs6498122 at CIITA gene are associated with OLP and could also indicate the autoimmune characteristics of OLP. Buccal swab instead of blood sample in SNPs genetic research can be used.
110
115

REFERENCES

References: 

[1] Zhang, Xiansen, et al. “mRNA expression of CK19, EGFR and LUNX in patients with lung cancer
micrometastasis.” Experimental and Therapeutic Medicine, Vol. 7, No. 2, 2014, pp. 360-64.
[2] Eisen, D., et al. “Number V Oral lichen planus: Clinical features and management.” Oral Diseases, Vol. 11, No.
6, 2005, pp. 338-49.
[3] Chaudhary, S. “Psychosocial stressors in oral lichen planus.” Australian Dental Journal, Vol. 49, No. 4, 2004,
pp. 192-95.
[4] Al-Drobie, Ban F. “Assessment of microvessels density and inflammatory status in oral lichen planus.” Journal
of Baghdad College of Dentistry, Vol. 25, No. 1, 2013, pp. 43-47.
[5] Sugerman, P.B., et al. “The pathogenesis of oral lichen planus.” Critical Reviews in Oral Biology & Medicine, Vol.
13, No. 4, 2002, pp. 350-65.
[6] Reith, Walter, Salomé LeibundGut-Landmann, and Jean-Marc Waldburger. “Regulation of MHC class II gene
expression by the class II transactivator.” Nature Reviews Immunology, Vol. 5, No. 10, 2005, pp. 793-806.
[7] Wu, Dan, et al. “CIITA rs4774 and rs6498122 polymorphisms are associated with oral lichen planus in Chinese
people: a case–control study.” European Journal of Oral Sciences, Vol. 121, No. 2, 2013, pp. 69-75.
[8] Bronson, Paola G., et al. “The rs4774 CIITA missense variant is associated with risk of systemic lupus
erythematosus.” Genes and Immunity, Vol. 12, No. 8, 2011, pp. 667-71.
[9] Koizumi, K., et al. “Single nucleotide polymorphisms in the gene encoding the major histocompatibility complex
class II transactivator (CIITA) in systemic lupus erythematosus.” Annals of the Rheumatic Diseases, Vol. 64, No.
6, 2005, pp. 947-50.
[10] Bronson, Paola G., et al. “CIITA is not associated with risk of developing rheumatoid arthritis.” Genes and
Immunity, Vol. 12, No. 3, 2011, pp. 235-38.
[11] Eike, M.C., et al. “CIITA gene variants are associated with rheumatoid arthritis in Scandinavian populations.” Genes
and Immunity, Vol. 13, No. 5, 2012, pp. 431-36.
[12] Morikawa, Akemi, et al. “Expression of beclin-1 in the microenvironment of invasive ductal carcinoma of
the breast: correlation with prognosis and the cancer-stromal interaction.” PloS one, Vol. 10, No. 5, 2015, p.
e0125762.
[13] Zuhair, Ahmed, Jassim Al-Waeli, and Frial Jameel Abd. “New term (SNPs-genotypes combination principal)
gives better understanding about effect of SNPs on the concentration of IL-1β and TNFα in clinical samples of
periodontitis.” Journal of Chemical and Pharmaceutical Sciences, Vol. 9, No. 4, pp. 3239-44.
[14] Ting, J. P., and J. Trowsdale. “Genetic control of MHC class II expression. Cell 109.” S21–S33 (2002).
Al-Drobie, et al. Int J Med Res Health Sci 2018, 7(1): 110-115
115
[15] Reith, Walter, and Bernard Mach. “The bare lymphocyte syndrome and the regulation of MHC expression.” Annual
Review of Immunology, Vol. 19, No. 1, 2001, pp. 331-73.
[16] Janitz, Michal, et al. “Analysis of the sequence polymorphism within class II transactivator gene
promoters.” Experimental and Clinical Immunogenetics, Vol. 18, No. 4, 2001, pp. 199-205.
[17] Garcia-Bermudez, M., et al. “Influence of MHCIITA rs3087456 and rs4774 polymorphisms in the susceptibility
to cardiovascular disease of patients with rheumatoid arthritis.” Clinical and Experimental Rheumatology, Vol.
30, No. 1, 2012, pp. 51-57.
[18] Ng, Pauline C., and Steven Henikoff. “Predicting deleterious amino acid substitutions.” Genome Research, Vol.
11, No. 5, 2001, pp. 863-74.

Thank you for copying data from http://www.arastirmax.com